• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Orthopedics

FDA says Alcyone Therapeutics can continue study of drug delivery implant

July 31, 2024 By Sean Whooley

Alcyone Therapeutics Logo

Alcyone Therapeutics announced today that the FDA approved continued enrollment in a study of its ThecaFlex DRx drug delivery system. The company can continue enrolling in the PIERRE FDA investigational device exemption study for the implantable medical device. It evaluates the system, comprised of a subcutaneous port and intrathecal catheter system. This system provides chronic […]

Filed Under: Drug-Device Combinations, Featured, Food & Drug Administration (FDA), Implants, Orthopedics, Pharmaceuticals Tagged With: Alcyone Lifesciences, Alcyone Therapeutics, FDA

Glucotrack expands CGM tech to spinal epidural space

April 16, 2024 By Sean Whooley

GlucoTrack

Glucotrack (Nasdaq:GCTK) announced today that it plans to expand its glucose monitoring technology to measure glucose in the epidural space. Rutherford, New Jersey-based Glucotrack said CGM taking readings in the spinal epidural space could integrate with existing treatments for painful diabetic neuropathy (PDN). Specifically, Glucotrack sees spinal cord stimulation (SCS) technology as a potential integration […]

Filed Under: Business/Financial News, Clinical Trials, Diabetes, Featured, Implants, Orthopedics, Pain Management Tagged With: Glucotrack

Evonik invests in Allay Therapeutics to reduce need for opioids

December 13, 2022 By Sean Whooley

Allay Therapeutics Evonik

Evonik announced today that it invested in Allay Therapeutics and its implant for treating pain after knee surgery. Inserted directly into the knee, the Allay implant may relieve pain for up to three weeks, according to a news release. Previous solutions worked for a maximum of three days, the company said. The technology helps promote […]

Filed Under: Business/Financial News, Drug-Device Combinations, Implants, Orthopedics Tagged With: Allay Therapeutics, Evonik

Early study supports experimental hydrogel injection for chronic low back pain

June 13, 2022 By Sean Whooley

ReGelTec Hydrafil System Hydrogel

A study demonstrated that an experimental hydrogel formulation was safe and effective in substantially relieving chronic low back pain. Research presented at the Society of Interventional Radiology Annual Scientific Meeting in Boston supported the hydrogel, which was injected into spinal discs in an effort to relieve chronic low back pain caused by degenerative disc disease […]

Filed Under: Clinical Trials, Drug-Device Combinations, Featured, Hydrogels, Orthopedics, Pain Management Tagged With: hydrogels, ReGelTec

Ariste Medical co-founder sees great potential for drug-coated implants and orthopedics

April 18, 2022 By Jim Hammerand

Orange polypropylene mesh coated with antibiotics

It’s been more than a decade since Lisa Jennings launched not one but two companies in the Great Recession. In 2020, she sold CirQuest Labs to MLM Medical Labs, where Jennings serves as chief scientific officer and managing director of U.S. operations. More recently, her pre-commercial medtech development startup, Ariste Medical, won FDA 510(k) approval for […]

Filed Under: Drug-Device Combinations, Featured, Grafts, Implants, Materials Testing, Orthopedics, Pharmaceuticals, Research & Development, Stents, Uncategorized Tagged With: Ariste Medical, implantable devices

Locate Bio lands FDA breakthrough nod for bone infection device

January 7, 2021 By Nancy Crotti

Regenerative medicine company Locate Bio announced today that the FDA has granted breakthrough device designation to a bone graft/antibiotic combination designed to combat chronic bone infection, also known as osteomyelitis. Osteomyelitis is a progressive, inflammatory infection of the bone, usually caused by bacteria and is estimated to account for up to 50% of all non-trauma […]

Filed Under: Business/Financial News, Drug-Device Combinations, Featured, Food & Drug Administration (FDA), Orthopedics, Pharmaceuticals, Regenerative Medicine Tagged With: FDA, Locate Bio

OsteoRemedies wins FDA nod for Remedy Spectrum GV hip spacer and bone cement

November 1, 2018 By Danielle Kirsh

OsteoRemedies-logo

OsteoRemedies recently announced that it has received FDA clearance for its Remedy Spectrum GV hip spacer system and Spectrum GV bone cement. The system is designed to give surgeons a broad spectrum of treatment options with both Gentamicin and Vancomycin. “We are very proud to have the first FDA cleared dual-antibiotic spacer system and bone […]

Filed Under: Orthopedics Tagged With: OsteoRemedies

Flexion reports data from Phase II bilateral osteoarthritis trial

October 22, 2018 By Sarah Faulkner

Flexion Therapeutics - updated logo

Flexion Therapeutics (NSDQ:FLXN) touted data today from a Phase II trial assessing the bilateral dosing of its extended-release triamcinolone acetonide injection in people with bilateral osteoarthritis. The study found that bilateral injections of Flexion’s Zilretta therapy resulted in lower plasma concentrations of triamcinolone acetonide compared to immediate-release triamcinolone acetonide in crystalline suspension (TAcs). The company also […]

Filed Under: Clinical Trials, Drug-Device Combinations, Featured, Orthopedics, Wall Street Beat Tagged With: Flexion Therapeutics

Genentech wins FDA nod for subcutaneous formulation of arthritis drug

September 14, 2018 By Sarah Faulkner

Genentech logo updated

Roche‘s (OTC:RHHBY) Genentech reported this week that the FDA approved the subcutaneous formulation of tocilizumab for the treatment of active systemic juvenile idiopathic arthritis in patients two years and older. The U.S. agency approved the intravenous formulation of Actemra for the same indication in 2011. Systemic juvenile idiopathic arthritis affects roughly 30,000 children in the U.S., according […]

Filed Under: Featured, Food & Drug Administration (FDA), Orthopedics, Pharmaceuticals, Regulatory/Compliance, Wall Street Beat Tagged With: Genentech

Medtech stories we missed this week: August 3, 2018

August 3, 2018 By Danielle Kirsh

missed-medtech-0803

From Esaote launching its new ultrasound device to Nipro’s Infraredx launching in Japan, here are seven medtech stories we missed this week but thought were still worth mentioning. 1. Esaote launches new ultrasound devices Esaote announced in an Aug. 2 press release that it has launched its new MyLab X7, MyLab X6 and MyLab X5 ultrasound systems. […]

Filed Under: Diagnostics, Featured, Food & Drug Administration (FDA), Hospital Care, Imaging, Implants, Orthopedics, Patient Monitoring, Regulatory/Compliance Tagged With: Bonesupport, Esaote, Infraredx, ivwatch, medtech, Mindshare Medical, Modulated Imaging, MTF Biologics, Nipro

  • Page 1
  • Page 2
  • Page 3
  • Interim pages omitted …
  • Page 7
  • Go to Next Page »

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS